High Risk Myeloma Treatment Options
Myeloma is classified as high-risk based on presence of cytogenetic abnormalities and poor treatment outcomes. Despite many new drugs and drug combinations being approved, long term benefits for high risk multiple myeloma patients is less clear. We continue our discussion on high risk myeloma with Dr. Robert Orlowski and talk about the treatment options that are available for a high risk patient.
CureTalks is an online Talk featuring a leading expert in conversation with a panel and the audience. The audience can ask questions from the panelists LIVE on the talk by dial-ing in. To hear the talk via phone or on-line, please add your email on the left; we will send you Live Talk access details. You can also write your questions in the Comments/Questions section below and your question maybe selected to be featured on the talk.